Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes (Q46689486)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
scientific article

    Statements

    Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit